Drug Page

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

A new study reports that the supplement EPA improved ADHD symptoms but a closer look calls these results into question.

Researchers compared the efficacy of antidepressants using different rating scales and found them to be no different—just slightly better than placebo, and not meeting the criteria for clinical significance.

The use of antidepressants has risen quickly among older adults but the rate of depressive symptoms in this population has not declined as a result.

A clinical trial finds Prozac no better than placebo for improving repetitive behaviors.

Researchers shed light on the precarious nature of evidence from efficacy trials of antidepressant medication to treat symptoms of major depressive disorder in children and adolescents.

Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

Clinical trials also consistently fail to measure and report long-term harmful effects.

A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

Despite their finding, the researchers suggest that SSRIs be given to people who do not meet criteria for depression or anxiety.

A new study found that taking an antidepressant medication was associated with a heightened risk of suicide using violent means.

A new study has found that antidepressants are ineffective for reducing suicide attempts. Researchers report that the risk of suicide is particularly high in the first month after starting an antidepressant.

New review of long-term depression data finds psychotherapy more effective over time whereas antidepressants decrease in effectiveness.

Ethnographic research sheds light on extensive psychopharmaceutical use by soldiers in post 9/11 U.S. wars.

Adhering to a commonly prescribed medication for ADHD in children is associated with higher chances of being prescribed antidepressants in adolescence.

Researchers, publishing in Toxicology Research, review the evidence that antidepressant exposure in the womb is linked to autism spectrum disorders (ASD) in humans.

Researchers experimenting on mice found that exposure to fluoxetine (Prozac) in utero resulted in behaviors considered in animal studies to be analogous to autism in humans.

A new meta-review examines the experiences of antipsychotic drugs use among people diagnosed with a psychotic disorder.

Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.

Researchers question biases of preliminary trials that found that sodium nitroprusside, an antihypertensive drug, has positive effects on schizophrenia symptoms.

New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.

Could the statistical phenomenon of regression to the mean be responsible for the dramatic effects of placebo—as well as the supposed effectiveness of some psychiatric drugs?

Study reviews psychological interventions for antidepressant discontinuation.